PTPRC and inflammatory bowel disease: Using our method of identifying human intestinal macrophages, we first assessed the proportion of total macrophages (CD45+ CD64+ HLA-DR+) among total live cells in colonic biopsies from both non-IBD controls (labelled as healthy) and from patients with CD and UC.